Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma

被引：8
|
作者：
Bhattacharya, Anish [1 ]
Venkataramarao, Sunil Hejjaji [1 ]
Bal, Chandra Sekhar [2 ]
Mittal, Bhagwant Rai [1 ]
机构：
[1] PGIMER, Dept Nucl Med, Chandigarh, India
[2] AIIMS, Dept Nucl Med, New Delhi, India
来源：
INDIAN JOURNAL OF NUCLEAR MEDICINE | 2010年 / 25卷 / 01期
关键词：
Carcinoma; hybrid imaging; iodine-131; SPECT-CT; thyroid;
D O I：
10.4103/0972-3919.63599
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The management protocol for differentiated thyroid cancer includes whole body iodine-131 imaging, to detect residual thyroid tissue and distant metastasis, after thyroidectomy. However, the diagnostic dose of radioiodine may fail to detect the non-functioning or poorly functioning metastasis. We present a case where hybrid single photon-emission computed tomographic and computed tomographic (SPECT-CT) fusion imaging, using a diagnostic dose of iodine-131, was able to detect both functioning as well as non-functioning pulmonary metastases, prior to high-dose radioiodine therapy.
引用
收藏
页码：29 / 31
页数：3
相关论文
共 50 条
  • [31] Role of post therapy 131-Iodine-SPECT/CT imaging in patients with thyroid cancer.
    Hassan, F.
    Mohan, H. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S446 - S446
  • [32] Value of SPECT and integrated low-dose CT in patients with thyroid carcinoma after radioiodine therapy
    Ruf, J
    Lehmkuhl, L
    Bertram, H
    Sandrock, D
    Amthauer, H
    Munz, DL
    Felix, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S356 - S356
  • [33] OUTCOME AFTER HIGH-DOSE RADIOIODINE THERAPY FOR ADVANCED DIFFERENTIATED THYROID CARCINOMA IN CHILDHOOD
    Gao, Yun-Chao
    Lu, Han-Kui
    ENDOCRINE RESEARCH, 2009, 34 (04) : 121 - 129
  • [34] Transformation of p53-Positive Papillary Thyroid Carcinoma to Anaplastic Carcinoma of the Liver following Postoperative Radioactive Iodine-131 Therapy
    Takeshita, Yumie
    Takamura, Toshinari
    Minato, Hiroshi
    Misu, Hirofumi
    Ando, Hitoshi
    Yamashita, Tatsuya
    Ikeda, Hiroko
    Nakanuma, Yasuni
    Kaneko, Shuichi
    INTERNAL MEDICINE, 2008, 47 (19) : 1709 - 1712
  • [35] 18F-FDG-PET scans and high dose of iodine-131 (I-131) treatment in patients with elevated thyroglobulin and negative iodine-131 scan differentiated thyroid carcinoma
    McEwan, Alexander
    Ma, Chao
    Morrish, Donald
    McMullen, Todd
    Capelle, Lisa
    Severin, Diane
    Jha, Naresh
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [36] Clinical Value of 131I-SPECT/CT Fusion Imaging in Patients with Differentiated Thyroid Carcinoma
    Ye, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S292 - S292
  • [37] Survival analysis of patients with locally advanced iodine-131 refractory papillary thyroid carcinoma treated with peptide receptor radionuclide therapy
    Vlajkovic, M.
    Matovic, M.
    Artiko, V.
    Matovina, E.
    Rajic, M.
    Stevic, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S374 - S374
  • [38] The merit of absorbed dose to the blood in iodine-131 therapy for differentiated thyroid carcinoma: One size does not fit all
    Assadi, Majid
    Fatholahi, Leila
    Tabeie, Faraj
    Javadi, Hamid
    Asli, Isa Neshandar
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [39] The merit of absorbed dose to the blood in iodine-131 therapy for differentiated thyroid carcinoma: One size does not fit all
    Assadi, Majid
    Fatholahi, Leila
    Tabeie, Faraj
    Javadi, Hamid
    Asli, Isa Neshandar
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [40] Impact of 131I SPECT/CT in the evaluation of differentiated thyroid carcinoma: fusion imaging versus planar imaging
    Palmieri, A.
    Bigi, G.
    Cola, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S450 - S451
12345